BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25210881)

  • 1. Estrogen-like potentiation of ghrelin-stimulated GH secretion by fulvestrant, a putatively selective ER antagonist, in postmenopausal women.
    Veldhuis JD; Yang RJ; Wigham JR; Erickson D; Miles JC; Bowers CY
    J Clin Endocrinol Metab; 2014 Dec; 99(12):E2557-64. PubMed ID: 25210881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary and/or peripheral estrogen-receptor alpha regulates follicle-stimulating hormone secretion, whereas central estrogenic pathways direct growth hormone and prolactin secretion in postmenopausal women.
    Cosma M; Bailey J; Miles JM; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2008 Mar; 93(3):951-8. PubMed ID: 18089703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous Estrogen Regulates Somatostatin-Induced Rebound GH Secretion in Postmenopausal Women.
    Veldhuis JD; Erickson D; Yang R; Takahashi P; Bowers C
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4298-4304. PubMed ID: 27459535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex steroids, GHRH, somatostatin, IGF-I, and IGFBP-1 modulate ghrelin's dose-dependent drive of pulsatile GH secretion in healthy older men.
    Veldhuis JD; Norman C; Miles JM; Bowers CY
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4753-60. PubMed ID: 22990092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estradiol potentiates ghrelin-stimulated pulsatile growth hormone secretion in postmenopausal women.
    Veldhuis JD; Keenan DM; Iranmanesh A; Mielke K; Miles JM; Bowers CY
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3559-65. PubMed ID: 16804038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral estrogen receptor-alpha selectively modulates the waveform of GH secretory bursts in healthy women.
    Veldhuis JD; Keenan DM; Bowers CY
    Am J Physiol Regul Integr Comp Physiol; 2007 Oct; 293(4):R1514-21. PubMed ID: 17686882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estradiol supplementation enhances submaximal feed-forward drive of growth hormone (GH) secretion by recombinant human GH-releasing hormone-1,44-amide in a putatively somatostatin-withdrawn milieu.
    Veldhuis JD; Evans WS; Bowers CY
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5484-9. PubMed ID: 14602794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term estradiol supplementation potentiates low-dose ghrelin action in the presence of GHRH or somatostatin in older women.
    Norman C; Rollene N; Weist SM; Wigham JR; Erickson D; Miles JM; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2014 Jan; 99(1):E73-80. PubMed ID: 24203062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of estradiol supplementation on dual peptidyl drive of GH secretion in postmenopausal women.
    Veldhuis JD; Evans WS; Bowers CY
    J Clin Endocrinol Metab; 2002 Feb; 87(2):859-66. PubMed ID: 11836333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preservation of GHRH and GH-releasing peptide-2 efficacy in young men with experimentally induced hypogonadism.
    Veldhuis JD; Keenan DM; Bailey JN; Miles JM; Bowers CY
    Eur J Endocrinol; 2009 Aug; 161(2):293-300. PubMed ID: 19458139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
    Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tripartite control of growth hormone secretion in women during controlled estradiol repletion.
    Veldhuis JD; Cosma M; Erickson D; Paulo R; Mielke K; Farhy LS; Bowers CY
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2336-45. PubMed ID: 17405836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulating Effects of Progesterone on Spontaneous Nocturnal and Ghrelin-Induced GH Secretion in Postmenopausal Women.
    Roelfsema F; Yang RJ; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2019 Jun; 104(6):2385-2394. PubMed ID: 30721950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen supplementation selectively enhances hypothalamo-pituitary sensitivity to ghrelin in postmenopausal women.
    Kok P; Paulo RC; Cosma M; Mielke KL; Miles JM; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4020-6. PubMed ID: 18611978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential pulsatile secretagogue control of GH secretion in healthy men.
    Norman C; Miles J; Bowers CY; Veldhuis JD
    Am J Physiol Regul Integr Comp Physiol; 2013 May; 304(9):R712-9. PubMed ID: 23485864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study.
    Bellantoni MF; Vittone J; Campfield AT; Bass KM; Harman SM; Blackman MR
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2848-53. PubMed ID: 8768841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre- versus postmenopausal age, estradiol, and peptide-secretagogue type determine pulsatile growth hormone secretion in healthy women: studies using submaximal agonist drive and an estrogen clamp.
    Hudson SB; Schroeder DR; Bailey JN; Mielke KL; Erickson D; Miles JM; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2010 Jan; 95(1):353-60. PubMed ID: 19858315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ghrelin potentiates growth hormone secretion driven by putative somatostatin withdrawal and resists inhibition by human corticotropin-releasing hormone.
    Veldhuis JD; Iranmanesh A; Mielke K; Miles JM; Carpenter PC; Bowers CY
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2441-6. PubMed ID: 16537682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel relationships of age, visceral adiposity, insulin-like growth factor (IGF)-I and IGF binding protein concentrations to growth hormone (GH) releasing-hormone and GH releasing-peptide efficacies in men during experimental hypogonadal clamp.
    Veldhuis JD; Keenan DM; Bailey JN; Adeniji AM; Miles JM; Bowers CY
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2137-43. PubMed ID: 19351723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estradiol regulates GH-releasing peptide's interactions with GH-releasing hormone and somatostatin in postmenopausal women.
    Norman C; Rollene NL; Erickson D; Miles JM; Bowers CY; Veldhuis JD
    Eur J Endocrinol; 2014 Jan; 170(1):121-9. PubMed ID: 24114435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.